This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Precision Medicine Conference" (IPMC 2023) scheduled during April 24-26, 2023 in Orlando, Florida, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at precision-medicine@magnusconference.com or call + 1 (702) 988 2320.
Precision medicine (PM) is a type of medicine that tries to enhance patient outcomes by stratifying or personalizing diagnosis and treatment decisions. Many factors influence the cost-effectiveness of targeted interventions, including the prevalence of a particular gene or allele in a population, the accuracy of a test, and the costs of testing and personalized treatment. The prevalence of the genetic "disease" in the target population, the costs of genetic testing and accompanying therapy, and the likelihood of complications or mortality were discovered to be the key elements that determine cost-effectiveness.
Precision medicine divides patients into subgroups so that focused interventions can be developed. This raises concerns regarding privacy, informed consent, and social justice on an ethical level. It also raises concerns regarding cost, what to do with erroneous data, and the function of genetic stratification in patient treatment and monitoring.
Title : Copper (II) complexes as potential anticancer agents
Salah S Massoud, University of Louisiana, United States
Title : Leveraging blockchain technology, edge computing and federated learning to enhance outcomes in precision medicine
Ingrid Vasiliu Feltes, MEDNAX, United States
Title : The new horizons in the patient- centered care for understanding of the reasons of its health problems – Psychosynthesis approach
Ewa Danuta Bialek, Institute of Psychosynthesis, Poland
Title : Hegazy theory for interpretation of human parthenogenesis: A new hypothesis
Abdelmonem Awad Hegazy, Zagazig University, Egypt
Title : Precision Oncology and Personalised Medicine: Innovative Technology for the Treatment of Colorectal Cancer
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : The role of CD44v6 as a new immunotherapy target for urothelial cancer
Iris Adriana Maria Lodewijk, Institute of Biomedical Research, Spain